Skip to content
Telehealth Graded
State guide

Apple Health and GLP-1s in Washington

Apple Health won't pay for Wegovy or Zepbound to lose weight, and says so in one flat sentence in each drug's policy. What makes Washington worth reading is the rest of the page: two other routes are open, both are written down with numbers attached, and both are strict.

Every source on this page was read first-hand in September 2026, and each one below carries the date printed on the document itself.

2
documents cited
7
sourced facts
2
primary sources

What changed, and what the document says

  1. Wegovy, for weight loss

    Not covered

    Refused outright, citing a state rule and the federal statute that makes the benefit optional.

    “Semaglutide injection or tablet (Wegovy®) is not covered by Apple Health for weight loss in accordance with:”

    Washington State Health Care Authority — Apple Health (Medicaid) drug coverage criteria — Effective Date: 2/1/2026

  2. Zepbound, for weight loss

    Not covered

    Same answer, same two citations, in a separate policy of its own.

    “Tirzepatide (Zepbound®) is not covered by Apple Health for weight loss”

    Washington State Health Care Authority — Apple Health (Medicaid) drug coverage criteria — Effective Date: 5/1/2025

  3. The door Wegovy still has

    Conditions apply

    Established cardiovascular disease, spelled out event by event. A risk factor won't do it.

    “4. Patient has established cardiovascular disease with one or more of the following: a. Prior stroke (ischemic or hemorrhagic); OR b. Prior myocardial infarction (MI); OR”

    Washington State Health Care Authority — Apple Health (Medicaid) drug coverage criteria — Effective Date: 2/1/2026

  4. And you have to already be on treatment

    Conditions apply

    The prescription doesn't stand alone. Something else for the heart has to be running alongside it.

    “5. Treatment plan includes the following: a. Concurrent use of either of the following for secondary prevention of adverse CV events unless medication is contraindicated or not tolerated (i, ii, or iii):”

    Washington State Health Care Authority — Apple Health (Medicaid) drug coverage criteria — Effective Date: 2/1/2026

  5. The door Zepbound still has

    Conditions apply

    Sleep apnea, measured. Fifteen events an hour, attested by the prescriber, without a machine helping.

    “Provider attestation that patient has moderate to severe obstructive sleep apnea as defined as AHI or RDI ≥ 15 obstructive respiratory events per hour (apneas, hypopneas, or RERAs), without the use of a positive airway pressure device (PAP); AND”

    Washington State Health Care Authority — Apple Health (Medicaid) drug coverage criteria — Effective Date: 5/1/2025

  6. Renewal wants proof it worked

    Context

    Three things count as evidence, and one of them is the weight itself.

    “Documentation is submitted demonstrating a positive clinical response [e.g., weight loss, fewer AHIs per hour of sleep, or improved systolic blood pressure].”

    Washington State Health Care Authority — Apple Health (Medicaid) drug coverage criteria — Effective Date: 5/1/2025

  7. How long an approval lasts

    Context

    Six months to start, on both drugs.

    “If ALL criteria are met, the request will be authorized for 6 months.”

    Washington State Health Care Authority — Apple Health (Medicaid) drug coverage criteria — Effective Date: 2/1/2026

Telehealth in Washington

Some providers pay us a commission when you sign up through our links, at no extra cost to you.

Which of these companies serve Washington?

Of the 284 companies we grade, 28 publish a list of the states they are licensed in. We checked 250 more and found no such list on any page we read; 6 we have not checked either way.

21 of those lists name Washington: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon, Peak Wellness, Sprout Health, Allara Health, and MEDvidi. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.

Sources

Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.